Celgene's top product revenues 2013-2018

This statistic reveals the revenues generated by biotech company Celgene's top products between 2013 and 2018. In 2014, one of the company's top products, Otezla, generated revenues of around 70 million U.S. dollars. Otezla's annual revenue increased up to 1.6 billion dollars until 2018. Celgene Corporation is headquartered in Summit, New Jersey. The company is specialized on drug manufacturing for cancer and inflammatory disorders.

Revenues of biotech company Celgene's top products from 2013 to 2018

Drug name (therapy area)201320142015201620172018
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2019



Survey time period

2013 to 2018

Supplementary notes

Figures before 2016 were taken from previous annual reports.
No value means no data available.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Oncology"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.